G

GO Therapeutics

11 employees

A new generation of cancer immunotherapy promise to change the paradigm of cancer treatment.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Cellular engineering
Antobody developement
O-glycosylation
Antigen development
Health Care
Glycoproteomics
Glycopeptides
Drug development

Date founded

2014

Funding rounds raised

Total raised

$5M

from 1 investors over 1 rounds

G

GO Therapeutics raised $5M on August 17, 2017

Investors: Shenzhen Salubris Pharmaceuticals Co.,LTD

FAQ